Vivos Therapeutics Inc
NASDAQ:VVOS 2:47:46 PM EDT
| Market Cap (Intraday) | 7.45M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.85 |
| 50-Day MA | $4.32 |
| 200-Day MA | $6.99 |
Vivos Therapeutics Inc Stock, NASDAQ:VVOS
7921 Southpark Plaza, Suite 210, Littleton, Colorado 80120
United States of America
Phone: +1.844.908.4867
Number of Employees: 114
Description
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.